Treatment of Perioral Dermatitis in Children Under 11 Years

Managing perioral dermatitis in children younger than 11 years requires careful treatment selection. Patient age is a clinically significant factor that directly determines which therapies are appropriate and which are not.

Clinical Scenario

This protocol applies to patients with perioral dermatitis who are under 11 years of age. Younger patients carry specific age-related contraindications that limit the range of acceptable treatment options compared with older children and adults.

Treatment Approach

Management relies on antibiotic therapy — delivered via certain oral and topical routes — selected specifically for safety in this age group. At least one widely used antibiotic class that is standard in adults is contraindicated here due to age-related risk.

Full regimen details, sequencing, and prescribing guidance are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

Acceptable treatment for children includes oral and topical erythromycin as well as topical metronidazole.

To prevent poststeroid flare, oral tetracyclines are contraindicated for children who are less than 11 years old.

DOI: 10.1016/j.clindermatol.2013.05.034

View source ↗